shutterstock_728117296_-nicolo-zangirolami

Nicolo Zangirolami / Shutterstock.com

30 September 2019BiotechnologyMaxim Sobolev

Secondary patents: Moscow mewl

The Russian IP ombudsman Anatoly Semenov has written to the Russian lower house, the State Duma, drawing its attention to the increasing number of patent conflicts among pharmaceutical manufacturers in Russia and urged the Duma to legislate to address the issue.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

Sandoz wins $137.2m payout for lost profits in generic launch

Dexcom suffers second patent revocation at hands of UPC

Sanofi signs global rights deal to develop rare cancer therapy

Does the UPC offer a fresh take on patent validity?

Litigation implications of the USPTO’s terminal disclaimer proposal

Ipsen files further suit against CSPC over pancreatic cancer drug generic

Federal Circuit denies rehearing in heart valve case

FTC endorses greater access to affordable biosimilars